Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular DiseaseCirculation research, 2021-05, Vol.128 (11), p.1728-1746 [Peer Reviewed Journal]ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/circresaha.121.319077 ;PMID: 33998272Full text available |
2 |
Material Type: Article
|
![]() |
How Common Is Residual Inflammatory Risk?Circulation research, 2017-02, Vol.120 (4), p.617-619 [Peer Reviewed Journal]2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Feb 17, 2017 ;ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.116.310527 ;PMID: 28209792Full text available |
3 |
Material Type: Article
|
![]() |
Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?The New England journal of medicine, 2018-10, Vol.379 (16), p.1572-1574 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMe1812000 ;PMID: 30332575Full text available |
4 |
Material Type: Article
|
![]() |
LDL cholesterol: controversies and future therapeutic directionsThe Lancet (British edition), 2014-08, Vol.384 (9943), p.607-617 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61009-6 ;PMID: 25131980 ;CODEN: LANCAOFull text available |
5 |
Material Type: Article
|
![]() |
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)Journal of thrombosis and haemostasis, 2009-07, Vol.7, p.332-339 [Peer Reviewed Journal]2009 International Society on Thrombosis and Haemostasis ;ISSN: 1538-7933 ;ISSN: 1538-7836 ;EISSN: 1538-7836 ;DOI: 10.1111/j.1538-7836.2009.03404.x ;PMID: 19630828Full text available |
6 |
Material Type: Article
|
![]() |
Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agentsEuropean heart journal, 2016-05, Vol.37 (17), p.1373-1379 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com. ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com. 2016 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw046 ;PMID: 26916794Full text available |
7 |
Material Type: Article
|
![]() |
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsThe New England journal of medicine, 2019-02, Vol.380 (8), p.752-762 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Copyright © 2018 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809798 ;PMID: 30415610Full text available |
8 |
Material Type: Article
|
![]() |
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary DiseaseThe New England journal of medicine, 2016-12, Vol.375 (24), p.2349-2358 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1605086 ;PMID: 27959714Full text available |
9 |
Material Type: Article
|
![]() |
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trialThe Lancet (British edition), 2012-08, Vol.380 (9841), p.565-571 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11-Aug 17, 2012 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61190-8 ;PMID: 22883507 ;CODEN: LANCAOFull text available |
10 |
Material Type: Article
|
![]() |
Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for LongevityNutrition reviews, 2007-12, Vol.65 (12), p.253-259 [Peer Reviewed Journal]ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1301/nr.2007.dec.S253-S259Full text available |
11 |
Material Type: Article
|
![]() |
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular DiseaseJournal of the American College of Cardiology, 2020-05, Vol.75 (17), p.2122-2135 [Peer Reviewed Journal]2020 American College of Cardiology Foundation ;Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.02.059 ;PMID: 32354380Full text available |
12 |
Material Type: Article
|
![]() |
Lipoprotein(a) and Cardiovascular Risk Prediction Among WomenJournal of the American College of Cardiology, 2018-07, Vol.72 (3), p.287-296 [Peer Reviewed Journal]2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 17, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.04.060 ;PMID: 30012322Full text available |
13 |
Material Type: Article
|
![]() |
High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin TherapyCirculation (New York, N.Y.), 2013-09, Vol.128 (11), p.1189-1197 [Peer Reviewed Journal]2013 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2014 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.002671 ;PMID: 24002795 ;CODEN: CIRCAZFull text available |
14 |
Material Type: Article
|
![]() |
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)The American heart journal, 2011-10, Vol.162 (4), p.597-605 [Peer Reviewed Journal]Mosby, Inc. ;2011 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2011 Mosby, Inc. All rights reserved. ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2011.06.012 ;PMID: 21982649 ;CODEN: AHJOA2Full text available |
15 |
Material Type: Article
|
![]() |
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular diseaseClinical chemistry (Baltimore, Md.), 2009-02, Vol.55 (2), p.209-215 [Peer Reviewed Journal]Copyright American Association for Clinical Chemistry Feb 2009 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2008.119214 ;PMID: 19095723Full text available |
16 |
Material Type: Article
|
![]() |
Targeting cardiovascular inflammation: next steps in clinical translationEuropean heart journal, 2021-01, Vol.42 (1), p.113-131 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020 ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa099 ;PMID: 32176778Full text available |
17 |
Material Type: Article
|
![]() |
Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coinEuropean heart journal, 2016-06, Vol.37 (22), p.1720-1722 [Peer Reviewed Journal]ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw024 ;PMID: 26908943Full text available |
18 |
Material Type: Article
|
![]() |
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialThe Lancet (British edition), 2018-01, Vol.391 (10118), p.319-328 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 27, 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32814-3 ;PMID: 29146124Full text available |
19 |
Material Type: Article
|
![]() |
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regionsThe Lancet global health, 2019-10, Vol.7 (10), p.e1332-e1345 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 2214-109X ;ISSN: 2572-116X ;EISSN: 2214-109X ;DOI: 10.1016/S2214-109X(19)30318-3 ;PMID: 31488387Full text available |
20 |
Material Type: Article
|
![]() |
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudyEuropean heart journal, 2022-12, Vol.43 (46), p.4832 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehac444 ;PMID: 35943897Full text available |